Answers are grounded in this paper and cite their sources.
Advances in deep learning hold promise for predicting clinical factors from human brain images. In this study, we applied a spherical harmonics-based convolutional neural network approach (SPHARM-Net) to MRI-derived brain shape metrics to predict age, sex, and Alzheimer’s disease (AD) diagnosis. MRI-derived brain features included vertex-wise cortical curvature, convexity, thickness, and surface area. SPHARM-Net performs convolutions using the spherical harmonic transforms, eliminating the need to explicitly define neighborhood size, and achieving rotational equivariance. Sex classification and age regression were carried out in a large sample of healthy adults (UK Biobank; N=32,979), and AD classification performance was tested in a large, publicly available sample (ADNI; N=1,213). SPHARM-Net showed strong performance for sex classification (accuracy=0.91; balanced accuracy= 0.91; AUC=0.97), and age regression (average absolute error=2.97 years; R-squared=0.77; Pearson's coefficient=0.9). AD classification also performed well (accuracy=0.86; balanced accuracy=0.83; AUC=0.9). Our experiments demonstrate promising preliminary performance using the SPHARM-Net for two widely studied benchmarking tasks and for AD classification. Future work will include comparisons of shape-based methods and extending these analysis to more challenging tasks such as mood disorder classification.
No takes yet. Share an insight, caveat, or question.
Im et al. (2025) studied this question.
Synapse has enriched 7 closely related papers on similar clinical questions. Consider them for comparative context: